癌痛规范化管理对肿瘤患者依从性及治疗效果影响.docVIP

  • 10
  • 0
  • 约4.2千字
  • 约 8页
  • 2018-09-16 发布于福建
  • 举报

癌痛规范化管理对肿瘤患者依从性及治疗效果影响.doc

癌痛规范化管理对肿瘤患者依从性及治疗效果影响

癌痛规范化管理对肿瘤患者依从性及治疗效果影响   摘要:目的 探讨癌痛患者规范化管理对患者依从性及治疗效果的影响。方法 随意抽取肿瘤科无痛病房创建前(2013年6月~11月)及无痛病房创建后(2013年12月~2014年5月)收治的晚期癌症并伴有中重度癌痛患者各154例为研究对象,按照无痛病房管理的实施时间分为对照组和观察组,对照组给予常规疼痛管理;观察组给予无痛病房规范化管理,10 d后比较两组患者癌痛缓解率和患者服药依从性。结果 观察组患者癌痛缓解率及和患者服药依从性高于对照组,差异有统计学意义(P0.05)。结论 癌痛规范化管理提高了护理人员疼痛管理意识和技能,增强了患者服药的依从性,使疼痛得到明显缓解。   关键词:癌痛;规范化管理;依从性;治疗效果   Abstract:Objective To investigate the effect of standardized management of patients with cancer pain patient compliance and therapeutic efficacy. Methods Painless oncology ward at random to create the front (From June to November in 2013) and painless ward creation (From December in 2013 to May in 2014) were treated with advanced cancer and moderate to severe cancer pain each 154 cases for the study, according to the implementation time painless ward , Management were divided into control group and observation group, the control group received conventional pain management; and the observation group were given standardized management painless wards, After ten days,the two groups were compared with pain response rates and patient medication compliance. Results There is a higher level in observation group than the control group with response rates in patients with cancer pain and drug compliance, The difference was statistically significant (P 0. 05). Conclusion Pain management improves standardized of nursing pain management awareness and skills, and enhances the patient medication compliance, So that the pain has been significantly alleviated.   Key words:Cancer pain; Standardized management; Compliance; Treatment effect   癌痛即癌症疼痛,是中晚期癌症患者常见的症状之一,它是由癌症本身或抗癌治疗引起的,不仅给患者带来身体、心理等方面的痛苦,还严重影响患者的生活质量。受诸多传统观念的束缚,肿瘤规范化诊疗水平偏低,导致癌痛控制效果不够理想。目前,疼痛已成为继体温、脉搏、呼吸、血压4大生命体征之后的第5生命体征,日益受到重视[1]。   我院肿瘤科于2013年12月癌痛规范化治疗示范病房,实施无痛病房管理,提高了癌痛患者止痛治疗的依从性、满意度及生存质量。现报道如下。   1 资料与方法   1.1一般资料 随机选取肿瘤科无痛病房创建前(2013年6月~11月)及无痛病房创建后(2013年12月~2014年5月)收治的晚期癌症并伴有中重度癌痛患者各154例为研究对象,其中男179例,女129例。年龄29~77岁,中位年龄54.3岁。肺癌84例、直肠癌78例、乳腺癌67例、胃癌48例、小肠癌31例。入组标准:①均符合WHO诊断标准,确诊为晚期

文档评论(0)

1亿VIP精品文档

相关文档